Francois Peinado Ibarra
Dr. Francois Peinado Ibarra
UROLOGY
HEAD OF SERVICE
Olympia Medical-Surgical Center
Ruber Juan Bravo
Ruber Juan Bravo
General Information
Degree- Degree in Medicine, Complutense University of Madrid (12 de Octubre Hospital) (1983-1990).
- Residency in Urology at La Princesa Hospital, Madrid (1992-1997).
- Degree in Medicine and Surgery (Cum Laude Outstanding), Autonomous University of Madrid.
- The PhD Thesis was completed at the Department of Morphology of the same university (1993-1998).
- Stays in American hospitals (Miami and New York) (1997-2000-2004) and Paris (1999).
Techniques
- LASER PROSTATE
- PEYRONIE’S DISEASE PROSTATE SURGERY
- ERECTILE DYSFUNCTION
- XIAPEX FOR PEYRONIE’S DISEASE
- SHOCKWAVES
- ERECTILE DYSFUNCTION
- PEYRONIE’S DISEASE SURGERY
- PENIS SURGERY
- PROSTATE STUDY USING MULTIPARAMETRIC RESONANCE IMAGING
- IMAGE FUSION BIOPSY
Communications and Presentations
- Speaker at the International Pelvic Floor Course held in Madrid in March 2016.
- Speaker on Clinical evidence of the use of collagenase in Peyronie’s disease at the National Meeting of the Uro-Andrology Group in February 2016.
- Speaker at the course on Prostate Laser Surgery at La Luz Clinic in Madrid in February 2016.
- Speaker at the International Course on Penile Reconstructive Surgery at Puerta de Hierro Hospital, June 2015
- Speaker at the Urology Refresher Course at Santa Cristina Hospital in Madrid, November 2015.
- Speaker at the International Course on Penile reconstructive surgery at Puigvert Foundation, Barcelona, May 2016
- Speaker at the Urological Genital Surgery course at Puerta de Hierro Hospital, Madrid, July 2016
Awards and certifications
- Prize for the best paper on prostate cancer presented at the congress of the Spanish Urology Association (1993).
- President of the first congress of Spanish urology residents (Cadiz, 1996).
- "A tu Salud" Prize to the best urologist in Spain 2015, by the newspaper La Razón.
- Creator of the exchange scholarships with the University of Miami for Spanish urology residents sponsored by Astra-Zeneca laboratories.